
Lifespan Technologies has engineered a direct heparin binding assay for measurement of unfractionated heparin (UFH) in plasma. This assay directly measures heparin, not heparin’s effect on the clotting cascade.
a) suitable for measuring low molecular weight heparin (LMWH) in plasma in the range 0.1 to 30 µg per mL.
b) has been used with mouse, rat, rhesus and human plasmas.
c) suitable for LMWH pharmacokinetics and clinical research.
d) this kit has been utilized in clinical trials.


